<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kapoor, Rinki</style></author><author><style face="normal" font="default" size="100%">Wadman, Mayken W</style></author><author><style face="normal" font="default" size="100%">Dohm, Michelle T</style></author><author><style face="normal" font="default" size="100%">Czyzewski, Ann M</style></author><author><style face="normal" font="default" size="100%">Spormann, Alfred M</style></author><author><style face="normal" font="default" size="100%">Barron, Annelise E</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms.</style></title><secondary-title><style face="normal" font="default" size="100%">Antimicrobial agents and chemotherapy</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Antimicrob. Agents Chemother.</style></alt-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011 Jun</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">55</style></volume><pages><style face="normal" font="default" size="100%">3054-7</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">The resistance of biofilms to conventional antibiotics complicates the treatment of chronic cystic fibrosis (CF). We investigated the effects of peptoids, peptides, and conventional antibiotics on the biomass and cell viability within Pseudomonas aeruginosa biofilms. At their MICs, peptoids 1 and 1-C13(4mer) caused maximum reductions in biomass and cell viability, respectively. These results suggest that peptoids of this class could be worth exploring for the treatment of pulmonary infections occurring in CF patients.</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/21422218?dopt=Abstract</style></custom1></record></records></xml>